B. Braun Medical Recalls Lots of Heparin After Dangeorus Contaminant Found in Product
B. Braun Medical Inc. recalled 23 lots of its blood thinner on March 21, 2008 after being notified by its supplier of a nationwide recall of Heparin Sodium USP because of a contaminant, according to Reuters.
B. Braun Medical, of Irvine, California, began recalling the lots on March 21
as a precautionary measure, after Scientific Protein Laboratories said
that one lot of Heparin Sodium, USP Active Pharmaceutical Ingredient it bought
has a heparin-like contaminant.
The U.S. Food and Drug Administration has
received reports of serious injuries and/or deaths in patients who have been
administered heparin injectable products of other companies containing this
contaminant.
The FDA recommends
that physicians, dialysis center staff and
health care providers use an alternate source of heparin or another
blood-thinning drug when possible.
If you were harmed after being
administered heparin, please complete the form below and a representative of our
firm will contact you as soon as possible.
see also:
Heparin Lawsuits
Japanese Firms Recall Heparin as Lawsuits Mount in the United StatesLawsuits Mount as People Come Forward with Heparin Related Injuries
Heparin & Surgery
Blood Thinner Heparin Used in People Undergoing Heart SurgeryMillions in US Have Been Treated With Heparin During Surgery--law info
Heparin News, 2.28.07
Breaking News: Baxter Recalls Most Heparin Products After 4 DieHeparin Pulled From Market After News of Illness--Free Lawsuit Info


